Santa Barbara, CA, United States of America

Renwei Chen


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renwei Chen: Innovator in Oral Drug Delivery Technologies

Introduction

Renwei Chen is a notable inventor based in Santa Barbara, California. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on oral drug delivery devices. His research focuses on enhancing the effectiveness of drug administration using advanced techniques.

Latest Patents

Renwei Chen holds a patent for "Oral drug delivery devices and methods using iontophoresis." This patent discloses methods, systems, and devices designed for oral drug delivery. The method involves administering a drug delivery device orally to a subject in need of treatment and triggering iontophoresis. The device includes one or more active agents intended for delivery to the subject. The process can involve delivering the active agent to the intestinal mucosa after iontophoresis is triggered or simultaneously while applying iontophoresis. This innovative approach aims to improve the permeability of active agents across the intestine compared to traditional oral administration methods.

Career Highlights

Throughout his career, Renwei Chen has worked with prestigious institutions, including the University of California and Harvard College. His experience in these esteemed organizations has contributed to his expertise in drug delivery technologies and has allowed him to collaborate with leading researchers in the field.

Collaborations

Renwei Chen has collaborated with notable colleagues, including Amrita Banerjee and Shamsul Arafin. These partnerships have further enriched his research and development efforts in the area of oral drug delivery systems.

Conclusion

Renwei Chen's innovative work in oral drug delivery technologies showcases his commitment to advancing medical science. His patent on iontophoresis-based drug delivery devices represents a significant step forward in improving treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…